Diversified Trust’s Heron Therapeutics HRTX Stock Holding History

Diversified Trust’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.3K	Hold	26,492	–	–	﹤0.01%	1108
2026 Q1	$21.2K	Buy	+26,492	New	+$30.7K	﹤0.01%	1040
2024 Q3	–	Sell	-23,966	Closed	-$83.9K	–	933
2024 Q2	$83.9K	Hold	23,966	–	–	﹤0.01%	836
2024 Q1	$66.4K	Buy	+23,966	New	+$60.2K	﹤0.01%	807
2023 Q1	–	Sell	-18,863	Closed	-$47K	–	871
2022 Q4	$47K	Buy	+18,863	New	+$60.8K	﹤0.01%	782
2022 Q1	–	Sell	-18,151	Closed	-$166K	–	837
2021 Q4	$166K	Hold	18,151	–	–	0.01%	789
2021 Q3	$194K	Buy	18,151 +470	+3%	+$5.72K	0.01%	729
2021 Q2	$274K	Hold	17,681	–	–	0.01%	580
2021 Q1	$287K	Sell	17,681 -1,031	-6%	-$18.4K	0.01%	553
2020 Q4	$396K	Hold	18,712	–	–	0.02%	425
2020 Q3	$277K	Buy	18,712 +5,881	+46%	+$91.8K	0.01%	473
2020 Q2	$189K	Buy	+12,831	New	+$211K	0.01%	499

Other funds holding HRTX

CPC

Congress Park Capital Saratoga Springs, New York $370M AUM 26.01% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Apeiron RIA Dallas, Texas $390M AUM 22.97% 1-Year Est. Return

DIM

DLK Investment Management Solana Beach, California $235M AUM 12.41% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

TWM

TopTier Wealth Management Muskego, Wisconsin $166M AUM

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Diversified Trust's HRTX Position: Q2 2026 in Review

Diversified Trust held its Heron Therapeutics (HRTX) position steady in Q2 2026 at 26,492 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1108.

Diversified Trust first reported a position in HRTX in Q2 2020 and has held it in 12 quarters since. The position peaked at $396K in Q4 2020. 11 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

Diversified Trust held 26,492 shares of Heron Therapeutics worth $11.3K as of Q2 2026.
Diversified Trust left its Heron Therapeutics share count unchanged in Q2 2026.
Heron Therapeutics made up ﹤0.01% of Diversified Trust's portfolio in Q2 2026, its #1108 holding.
Diversified Trust first reported a position in Heron Therapeutics in Q2 2020 and has held it in 12 quarters since.
Diversified Trust's Heron Therapeutics position peaked at $396K in Q4 2020.
11 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.